During the past decade, Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine" #1 collaborator was "American Heart Association" with 1 trials as a collaborator, "CrystalGenomics, Inc." with 1 trials as a collaborator, "Ginger.io" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine" are "Healthy" (8 trials), "Healthy Aging" (1 trials), "Healthy Volunteers" (1 trials), "Hiv" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine" in a lesser frequency.

Most popular intervention types in "Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine" are "Drug" (5 trials), "Other" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Celecoxib" (2 trials), "Naproxen" (2 trials), "Placebo" (2 trials), "Acetaminophen" (1 trials) and "Acetazolamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".